annual operating expenses:
$391.32M-$70.97M(-15.35%)Summary
- As of today (June 29, 2025), CRSP annual total operating expenses is $391.32 million, with the most recent change of -$70.97 million (-15.35%) on December 31, 2024.
- During the last 3 years, CRSP annual operating expenses has fallen by -$47.06 million (-10.73%).
- CRSP annual operating expenses is now -30.54% below its all-time high of $563.35 million, reached on December 31, 2022.
Performance
CRSP Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$90.92M-$8.67M(-8.71%)Summary
- As of today (June 29, 2025), CRSP quarterly total operating expenses is $90.92 million, with the most recent change of -$8.67 million (-8.71%) on March 31, 2025.
- Over the past year, CRSP quarterly operating expenses has dropped by -$2.71 million (-2.89%).
- CRSP quarterly operating expenses is now -39.19% below its all-time high of $149.50 million, reached on June 30, 2022.
Performance
CRSP quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CRSP Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | -2.9% |
| 3 y3 years | -10.7% | -37.5% |
| 5 y5 years | +61.1% | +23.3% |
CRSP Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.5% | at low | -39.2% | at low |
| 5 y | 5-year | -30.5% | +61.1% | -39.2% | +23.3% |
| alltime | all time | -30.5% | +5804.9% | -39.2% | +1365.9% |
CRSP Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $90.92M(-8.7%) |
| Dec 2024 | $391.32M(-15.4%) | $99.59M(+0.6%) |
| Sep 2024 | - | $98.98M(-0.2%) |
| Jun 2024 | - | $99.13M(+5.9%) |
| Mar 2024 | - | $93.62M(-15.2%) |
| Dec 2023 | $462.29M(-17.9%) | $110.42M(+1.3%) |
| Sep 2023 | - | $108.99M(-9.6%) |
| Jun 2023 | - | $120.59M(-1.4%) |
| Mar 2023 | - | $122.30M(-1.9%) |
| Dec 2022 | $563.35M(+28.5%) | $124.72M(-13.2%) |
| Sep 2022 | - | $143.62M(-3.9%) |
| Jun 2022 | - | $149.50M(+2.7%) |
| Mar 2022 | - | $145.50M(+15.3%) |
| Dec 2021 | $438.38M(+23.5%) | $126.22M(+18.3%) |
| Sep 2021 | - | $106.71M(-3.5%) |
| Jun 2021 | - | $110.64M(+16.7%) |
| Mar 2021 | - | $94.80M(-12.2%) |
| Dec 2020 | $354.98M | $107.95M(+16.6%) |
| Sep 2020 | - | $92.55M(+14.6%) |
| Jun 2020 | - | $80.73M(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $73.74M(+11.7%) |
| Dec 2019 | $242.85M(+49.8%) | $66.03M(-9.3%) |
| Sep 2019 | - | $72.77M(+31.6%) |
| Jun 2019 | - | $55.30M(+13.4%) |
| Mar 2019 | - | $48.75M(+7.5%) |
| Dec 2018 | $162.07M(+53.4%) | $45.34M(-9.3%) |
| Sep 2018 | - | $49.99M(+30.3%) |
| Jun 2018 | - | $38.37M(+35.3%) |
| Mar 2018 | - | $28.36M(-9.6%) |
| Dec 2017 | $105.64M(+44.1%) | $31.35M(+20.8%) |
| Sep 2017 | - | $25.96M(+4.3%) |
| Jun 2017 | - | $24.89M(+6.1%) |
| Mar 2017 | - | $23.45M(-15.2%) |
| Dec 2016 | $73.29M(+182.2%) | $27.65M(+71.1%) |
| Sep 2016 | - | $16.16M(-6.9%) |
| Jun 2016 | - | $17.35M(+43.1%) |
| Mar 2016 | - | $12.13M(-2.3%) |
| Dec 2015 | $25.98M(+292.0%) | $12.41M(+100.1%) |
| Sep 2015 | - | $6.20M |
| Dec 2014 | $6.63M | - |
FAQ
- What is CRISPR Therapeutics AG annual total operating expenses?
- What is the all time high annual operating expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual operating expenses year-on-year change?
- What is CRISPR Therapeutics AG quarterly total operating expenses?
- What is the all time high quarterly operating expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly operating expenses year-on-year change?
What is CRISPR Therapeutics AG annual total operating expenses?
The current annual operating expenses of CRSP is $391.32M
What is the all time high annual operating expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total operating expenses is $563.35M
What is CRISPR Therapeutics AG annual operating expenses year-on-year change?
Over the past year, CRSP annual total operating expenses has changed by -$70.97M (-15.35%)
What is CRISPR Therapeutics AG quarterly total operating expenses?
The current quarterly operating expenses of CRSP is $90.92M
What is the all time high quarterly operating expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total operating expenses is $149.50M
What is CRISPR Therapeutics AG quarterly operating expenses year-on-year change?
Over the past year, CRSP quarterly total operating expenses has changed by -$2.71M (-2.89%)